Sensus Healthcare (SRTS) director lifts stake to 209K shares
Rhea-AI Filing Summary
Sensus Healthcare, Inc. (SRTS) director Eric Sachetta reported an open-market purchase of the company’s Common Stock. On 2026-08-24, he purchased 34,697 shares at a price of $3.254 per share, bringing his directly held position to 209,310 shares. He also reports 2,093 shares held indirectly through his spouse.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 34,697 shares
Net Buy
2 txns
Insider
Sachetta Eric
Role
Director
Bought
34,697 shs ($113K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 34,697 | $3.254 | $113K |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 209,310 shares (Direct);
Common Stock — 2,093 shares (Indirect, Spouse)
Key Figures
Shares purchased: 34,697 shares
Purchase price per share: $3.254 per share
Direct holdings after transaction: 209,310 shares
+2 more
5 metrics
Shares purchased
34,697 shares
Common Stock purchase on 2026-08-24
Purchase price per share
$3.254 per share
Common Stock transaction on 2026-08-24
Direct holdings after transaction
209,310 shares
Common Stock directly owned by Eric Sachetta after 2026-08-24 purchase
Indirect holdings (spouse)
2,093 shares
Common Stock held indirectly through spouse
Net buy shares
34,697 shares
Net buy direction per transaction summary
Key Terms
Common Stock, indirect ownership, Rule 10b5-1
3 terms
Common Stock financial
"security_title: "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
indirect ownership financial
"ownership_type" : "indirect""
Rule 10b5-1 regulatory
"Footnotes may reference Rule 10b5-1 trading plans"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
FAQ
What did SRTS director Eric Sachetta report in this Form 4?
He reported a purchase of 34,697 shares of Sensus Healthcare, Inc. Common Stock on 2026-08-24 at $3.254 per share, increasing his directly held shares to 209,310 and reporting 2,093 additional shares held indirectly through his spouse.
What are Eric Sachetta’s total direct SRTS holdings after this transaction?
Following the reported purchase, Eric Sachetta’s direct holdings of Sensus Healthcare, Inc. Common Stock total 209,310 shares, according to the Form 4’s post-transaction ownership figure.
Does the Form 4 show any indirect SRTS ownership by Eric Sachetta?
Yes. The Form 4 lists an indirect holding of 2,093 SRTS shares categorized under “Spouse” as the nature of ownership, in addition to his directly owned shares.
Was this SRTS insider transaction under a Rule 10b5-1 trading plan?
The filing’s Rule 10b5-1 checkbox is not marked as an affirmative plan (aff_10b5_one is false), indicating the transaction is not reported as executed under a Rule 10b5-1 trading plan.
AI-generated analysis. How Rhea-AI works. Not financial advice.
